BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9771389)

  • 21. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
    Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution of copper carboranyltetraphenylporphyrins in rodents bearing an isogeneic or human neoplasm.
    Miura M; Joel DD; Smilowitz HM; Nawrocky MM; Micca PL; Hoch DA; Coderre JA; Slatkin DN
    J Neurooncol; 2001 Apr; 52(2):111-7. PubMed ID: 11508810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
    Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
    Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
    Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
    Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
    Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Nawrocky M; Miura M
    Int J Radiat Biol; 2003 Mar; 79(3):149-58. PubMed ID: 12745879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.
    Kawabata S; Yang W; Barth RF; Wu G; Huo T; Binns PJ; Riley KJ; Ongayi O; Gottumukkala V; Vicente MG
    J Neurooncol; 2011 Jun; 103(2):175-85. PubMed ID: 20848301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
    Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
    BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
    Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
    Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boronated compounds for imaging guided BNCT applications.
    Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
    Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
    Masunaga S; Sakurai Y; Tanaka H; Suzuki M; Liu Y; Kondo N; Maruhashi A; Kinashi Y; Ono K
    Br J Radiol; 2012 Mar; 85(1011):249-58. PubMed ID: 22391496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular uptake of a new boronated porphyrin EC032.
    Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
    Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
    Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.